540222:BOM
Laurus Labs Ltd
₹ 2.059,00
arrow_upward
+1,93%(+39,00) 1D
16 okt, 15:59:49 GMT+5:30 · INR
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor 540222 genereren…
Openen
₹ 2.027,35
Hoog
₹ 2.086,00
Laag
₹ 2.027,35
Beursw.
1,11 bln.
Gem. vol.
84,29K
Volume
103,13K
Dividend
0,10%
Kwartaaldividend
₹ 0,50
Ex-dividenddatum
8 mei 2026
Koers/winst-verhouding
101,80
52 wk hoog
₹ 2.086,00
52 wk laag
₹ 870,05
WPA
₹ 20,23
Uitstaande aandelen
106,44 mln.
Aantal medewerkers
7K
Openen
₹ 2.027,35
Hoog
₹ 2.086,00
Laag
₹ 2.027,35
Beursw.
1,11 bln.
Gem. vol.
84,29K
Volume
103,13K
Dividend
0,10%
Kwartaaldividend
₹ 0,50
Ex-dividenddatum
8 mei 2026
Koers/winst-verhouding
101,80
52 wk hoog
₹ 2.086,00
52 wk laag
₹ 870,05
WPA
₹ 20,23
Uitstaande aandelen
106,44 mln.
Aantal medewerkers
7K
Nieuwsartikelen
Van webbronnen en nieuwspartners
The Economic Times
·
1 dag geleden
Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upside
Profiel
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
Over Laurus Labs Ltd